Global Payments stock price target raised to $105 by Raymond James

Raymond James has maintained a Market Perform rating on Palantir's stock, even after the company reported strong results for the third quarter. This decision reflects a cautious approach, suggesting that while Palantir's performance is commendable, there may be underlying concerns or market conditions that warrant a more reserved outlook. Investors should consider this perspective as they evaluate their positions in the stock.

Liquidia's stock price target has been raised from $41 to $47 by Raymond James, indicating strong confidence in the company's future performance. This adjustment reflects the analysts' positive outlook on Liquidia's growth potential and could attract more investors, boosting the stock's value.

Lattice Semiconductor has received a price target increase to $80 from Raymond James, reflecting strong confidence in the company's growth potential. This adjustment is significant as it highlights the positive outlook for Lattice's future performance, which could attract more investors and boost market interest.

Cigna's price target has been lowered to $350 by Raymond James due to changes in its pharmacy benefit management (PBM) contracts. This adjustment reflects concerns about the company's future profitability and market position, which could impact investors' confidence and the stock's performance. Understanding these shifts is crucial for stakeholders as they navigate the evolving landscape of healthcare management.

Raymond James has reaffirmed its 'Strong Buy' rating for Shake Shack's stock, especially following the launch of their new Big Shack burger. This endorsement is significant as it highlights investor confidence in the brand's growth potential and innovative menu offerings, which could attract more customers and boost sales.

The recent meeting between Trump and Xi has been deemed 'overall positive' by Raymond James, highlighting the potential for improved trade relations between the U.S. and China. This is significant as it could lead to a reduction in tariffs and foster a more stable economic environment, benefiting businesses and consumers alike.

Universal Health Services has received an upgrade to an 'Outperform' rating from Raymond James, signaling strong confidence in the company's future performance. This upgrade is significant as it reflects analysts' positive outlook on the healthcare sector, particularly for Universal Health Services, which is poised for growth. Investors may find this news encouraging as it suggests potential for increased stock value and improved financial health for the company.

Raymond James has upgraded its rating for Edwards Lifesciences to 'Outperform', indicating strong confidence in the company's future performance. This upgrade is significant as it reflects the firm's belief in Edwards' growth potential, particularly in the medical technology sector, which could lead to increased investor interest and potentially higher stock prices.

Molson Coors has reported a loss in the latest quarter, highlighting the challenges faced by the beer industry due to shifting consumer preferences and ongoing macroeconomic pressures.

Capital One has announced a quarterly dividend of $0.80 on its common stock, reflecting the company's strong financial performance and commitment to returning value to its shareholders.

Gold futures have dropped below the $4,000 per troy ounce mark, prompting analysts to describe this decline as a 'correction.' This downturn has raised concerns among investors about the stability of the gold market.

Roelof Botha, the managing partner of Sequoia Capital, has announced his departure from the firm after a challenging period. This leadership change marks a significant moment for the investment firm as it navigates through recent turbulence.

Roelof Botha, the managing partner of Sequoia Capital, has announced his departure from the firm after a challenging period. This leadership change marks a significant moment for the investment firm as it navigates through recent turbulence.

Ensign Group has reported a remarkable 19.8% increase in revenue for Q3 2025, prompting the company to raise its full-year guidance. This positive trend reflects strong performance and optimism for the future.